SEC Form 4 · accession 0001521123-26-000008
REGENXBIO Inc. · RGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick J. Christmas
Officer — Chief Strategy & Legal Officer
Period of report
Aug 1, 2026
Accepted (ET)
Aug 4, 2026 · 4:29 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001590877
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 1, 2026 | F | 4,699 | $9.69 | D | 205,968 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on August 1, 2024. The number of shares withheld was determined based on the closing price of the issuer's common stock on August 1, 2026.